European Respiratory Society Monograph, Vol. 98. 2022
ISBN (electronic): 978-1-84984-155-9
DOI: 10.1183/2312508X.erm9822
The coexistence of lung disease and cancer in the same person is a frequent occurrence. Evidence suggests that this coexistence sometimes goes beyond chance; in fact, both disease types are associated and the presence of one can be a risk factor or a protective factor for the other. In this Monograph,the Guest Editors bring together renowned clinical and scientific experts to provide an exhaustive review of the bidirectional relationship between respiratory diseases and cancer (not just lung cancer). The chapters: explore the common causal pathways of cancer and lung disease; consider the diseases from an epidemiological, clinical and therapeutic point of view; and discuss the many ways in which they interact to influence patient management. The result is a book that will generate a better understanding of this relationship, giving rise to a greater awareness of the possible development of lung disease in people with cancer, and of the different types of cancer that are frequently seen in those with lung diseases.
This site only provides online access to the book. To order a print copy, visit ersbookshop.com
Preface Peter M.A. Calverley Eur Respir Monogr 2022; 98: vii |  |
Guest Editors
Eur Respir Monogr 2022; 98: viii-x |  |
Introduction Miguel Ángel Martínez-García, Mina Gaga, Kwun M. Fong Eur Respir Monogr 2022; 98: xi-xiii |   |
List of abbreviations
Eur Respir Monogr 2022; 98: xiv |  |
Cancer immunosurveillance in respiratory diseases Carolina Cubillos-Zapata, Elena Díaz-García, Francisco García-Río Eur Respir Monogr 2022; 98: 1-14 |   |
Respiratory infections and cancer Jennifer Pollock, Chloe Hughes, James D. Chalmers Eur Respir Monogr 2022; 98: 15-30 |   |
Continuous and intermittent hypoxia in cancer Cliona O'Donnell, Ailbhe King, Silke Ryan Eur Respir Monogr 2022; 98: 31-47 |   |
Future challenges and their impact on respiratory health and lung cancer David Chi-Leung Lam, Yoichi Nakanishi, Yoshinosuke Fukuchi Eur Respir Monogr 2022; 98: 48-58 |   |
Smoking, vaping, nicotine and the risk of cancer Carlos A. Jiménez-Ruiz, Carlos Rabade-Castedo, Marcos García-Rueda, Eva Cabrera-César, Eva de Higes-Martinez Eur Respir Monogr 2022; 98: 59-70 |   |
Occupational exposure to respirable carcinogens and the risk of cancer Preston Ngo, Peter Sarich, Eleonora Feletto, Timothy Driscoll, Paul Grogan, Marianne Weber, Karen Canfell Eur Respir Monogr 2022; 98: 71-81 |   |
Exposure to thoracic radiation and the risk of cancer Catherine Bettington, Philip Chan, Gary Pratt Eur Respir Monogr 2022; 98: 82-90 |   |
COPD: the risk of cancer and the impact on cancer care Ian A. Yang, Janet G. Shaw, Edward K.H. Stephens, Tian Mun Chee, Edwina E. Duhig, Rayleen V. Bowman, Gerard N. Olive, Henry M. Marshall, Kwun M. Fong Eur Respir Monogr 2022; 98: 91-104 |   |
Emphysema: the risk of cancer and the impact on cancer care Jessica Gonzalez-Gutierrez, Pablo Sanchez-Salcedo, Juan P. de Torres Eur Respir Monogr 2022; 98: 105-117 |   |
Allergy: the risk of cancer and the impact on cancer care Thu-Phuong Phan, Giap Vu-Van, Bach Tran-Xuan, Ha Pham-Ngoc, Chau Ngo-Quy, Anh Tuan Dinh-Xuan Eur Respir Monogr 2022; 98: 118-122 |   |
Cystic fibrosis and bronchiectasis: the risk of cancer and the impact on cancer treatment Florie Akdime, Eloise Alabadan, Clémence Martin, Pierre-Régis Burgel Eur Respir Monogr 2022; 98: 123-133 |   |
Idiopathic pulmonary fibrosis: the risk of cancer and the impact on cancer care Carlo Vancheri Eur Respir Monogr 2022; 98: 134-144 |   |
Other interstitial lung diseases: the risk of cancer and the impact on cancer care Ivette Buendía-Roldán, Hiram Aguilar-Duran, Fortunato Juarez Eur Respir Monogr 2022; 98: 145-151 |   |
Viruses and the risk of lung cancer: prevention and treatment Catia Cillóniz, Juan M. Pericàs, Joseph A. Pinto Eur Respir Monogr 2022; 98: 152-162 |   |
Pulmonary tuberculosis and the risk of cancer Jean-Pierre Zellweger Eur Respir Monogr 2022; 98: 163-167 |   |
Obstructive sleep apnoea and the risk of cancer Miguel Ángel Martínez-García, Grace Oscullo, José Daniel Gómez-Olivas Eur Respir Monogr 2022; 98: 168-177 |   |
Venous thromboembolism: an indicator of malignancy Emily Sascha Louise Martens, Menno Volkert Huisman, Maarten Klemens Ninaber, Frederikus Albertus Klok Eur Respir Monogr 2022; 98: 178-189 |   |
Pulmonary metastasis: from pathophysiology to management Andriani Charpidou, Emmanouil Panagiotou, Stamatis Karakatsanis, Konstantinos Samitas, Kyriaki Tavernaraki, Iris Vlachantoni, Eleftherios Zervas, Mina Gaga Eur Respir Monogr 2022; 98: 190-200 |   |
Pulmonary metastasis from haematological cancers Stamatis Karakatsanis, Andriani Charpidou, Emmanouil Panagiotou, Konstantinos Samitas, Kyriaki Tavernaraki, Iris Vlachantoni, Eleftherios Zervas, Mina Gaga Eur Respir Monogr 2022; 98: 201-211 |   |
Pulmonary metastasis of solid tumours Eleftherios Zervas, Konstantinos Samitas, Iris Vlachantoni, Stamatis Karakatsanis, Emmanouil Panagiotou, Kyriaki Tavernaraki, Andriani Charpidou, Mina Gaga Eur Respir Monogr 2022; 98: 212-224 |   |
Interstitial abnormalities from solid and haematological cancers John A. Mackintosh, Edwina E. Duhig, Taryn Reddy, Edward K.H. Stephens, Kwun M. Fong, Ian A. Yang Eur Respir Monogr 2022; 98: 225-240 |   |
Pulmonary infections in cancer patients Sita Andarini, Farhan Hilmi Taufikulhakim, Salsabiila Maryam, Jamal Zaini Eur Respir Monogr 2022; 98: 241-252 |   |
Pulmonary effects of cancer treatments Theodoros Karampitsakos, Fotios Sampsonas, Paolo Spagnolo, Argyris Tzouvelekis Eur Respir Monogr 2022; 98: 253-264 |   |
Biological and immunosuppressive therapies for lung disease: a potential reciprocal influence between their use and malignancy Maria Gabriella Matera, Paola Rogliani, Andrea Bianco, Mario Cazzola Eur Respir Monogr 2022; 98: 265-280 |   |
Inhaled corticosteroids and lung cancer in COPD: evaluating their role in chemoprevention Hyun Lee, Don D. Sin Eur Respir Monogr 2022; 98: 281-298 |   |
Antibiotics for lung disease and cancer Antonella Arcadu, Margherita S. Silani, Francesco Amati, Andrea Gramegna, Francesco Blasi, Stefano Aliberti Eur Respir Monogr 2022; 98: 299-305 |   |